New Study: Global Visceral Pain Industry Trend and Forecast Report 2019-2025

1
Global Visceral Pain Market Size 2017

• By Therapeutics (Pain Modifiers, Analgesics, and
  Others), By Indications (Crohns Disease,
  Irritable Bowel, Interstitial Cystitis, Chronic
  Prostatitis), By Region and Forecast 2018 to 2025

Single Use License US 4200
Request Sample
2
Global Visceral Pain Market Size and Forecast,
2019-2025

• Adroit Market Research launched a study titled,
  Global Visceral Pain Market Size 2017, By
  Therapeutics (Pain Modifiers, Analgesics, and
  Others), By Indications (Crohns Disease,
  Irritable Bowel, Interstitial Cystitis, Chronic
  Prostatitis), By Region and Forecast 2018 to
  2025.
• The report covers global visceral pain market
  from 2015 to 2025 where 2015 to 2017 indicate
  historic data and forecast from 2018-2025. The
  report also highlights various market drivers,
  restraints and value chain of the global visceral
  pain industry. The global visceral pain market
  share has been provided on the basis of
  therapeutics and indications.
• By 2025, the global visceral pain market size is
  estimated to reach USD 15.16 billion driven by
  rising geriatric population and growing awareness
  regarding visceral pain. The increasing focus on
  research and development by major pharmaceutical
  companies and government initiatives is expected
  to propel the market growth. For instance, in
  January 2011, the federal agencies and the United
  States Department of Health and Human Services
  announced a PPP (Public Private Partnership)
  between China and the United States.
• The initiative is aimed at nurturing cooperation
  in research, training, and regulations. The
  initiative is led by major pharmaceutical giants
  such as Pfizer, Johnson Johnson, and Abbott
  Laboratories among others. The initiative is not
  just limited to RD of new vaccines and drugs but
  also aimed at providing global health security.
• Browse the complete report on _at_
  https//adroitmarketresearch.com/industry-reports/
  visceral-pain-market

3
Global Visceral Pain Market Size and Forecast,
2019-2025

• In terms of therapeutics, the global visceral
  pain market is segmented into analgesics, pain
  modifiers among others. The analgesics are
  further sub-segmented into narcotics and NSAID
  (Nonsteroidal anti-inflammatory drugs) whereas
  pain modifiers are further sub-segmented into
  tricyclic antidepressants and tricyclic
  anticonvulsants. The analgesic segment accounted
  for over 50 of the global visceral pain market
  share in 2017 and is expected to hold a lucrative
  demand in the forecast period. The demand for
  analgesics can be owed to the rising aging
  population, growing incidence cases of cancer
  patients, rising cardiovascular diseases, and
  arthritis among others.
• On the basis of indication, the global visceral
  pain market is categorized into interstitial
  cystitis, Crohn's, irritable bowel and chronic
  prostatitis. In the year 2017, the Crohn's
  disease accounted for major market share,
  however, the irritable bowel is expected to grow
  at the highest CAGR in the forecast period.
  According to The Crohns Colitis Foundation of
  America (CCFA), inflammatory bowel disease which
  comprises ulcerative colitis and Crohn's disease
  affect approximately 1.5 million individuals,
  most of which are diagnosed before the age of 35.
  The rising number of the same is expected to
  attribute to the growth of the visceral pain
  market.
• On the basis of region, the global visceral pain
  market was dominated by North America in 2017,
  however, the Asia Pacific market is likely to
  grow with the highest CAGR of 6.3 during the
  forecast period. In Asia Pacific, developing
  countries such as China, and India hold the
  maximum potential for the growth of visceral pain
  market. For instance, according to Nikkei Inc.,
  China is expected to become the second largest
  producer of OxyContin, one of the effective
  analgesics for many types of pain.
• Pfizer Inc., Johnson Johnson Services, Inc.,
  AbbVie Inc., Takeda Pharmaceutical Company
  Limited, ALLERGAN, AstraZeneca, ADDEX
  THERAPEUTICS, Astellas Pharma Inc. among other
  major players are the leading players present
  within the global visceral pain market.

4
Key segments of the global visceral pain market

• Therapeutics Overview, 2015-2025 (USD Million)
• Analgesic
• Narcotics
• NSAID
• Pain Modifiers
• Tricyclic Antidepressants
• Tricyclic Anticonvulsant
• Others
• Indications Overview, 2015-2025 (USD Million)
• Interstitial Cystitis
• Crohns
• Irritable Bowel
• Chronic Prostatitis

5
Key Segments of the Global Visceral Pain Market

• Regional Overview, 2015-2025 (USD Million)
• North America
• US
• Europe
• Germany
• United Kingdom
• Asia Pacific
• China
• India
• Rest of the World
• Purchase a single user copy of the global
  Visceral Pain market report _at_ https//adroitmarket
  research.com/researchreport/purchase/807

6
About Us

• Adroit Market Research is an India-based business
  analytics and consulting company. Our target
  audience is a wide range of corporations,
  manufacturing companies, product/technology
  development institutions and industry
  associations that require understanding of a
  markets size, key trends, participants and
  future outlook of an industry. We intend to
  become our clients knowledge partner and provide
  them with valuable market insights to help create
  opportunities that increase their revenues. We
  follow a code Explore, Learn and Transform. At
  our core, we are curious people who love to
  identify and understand industry patterns, create
  an insightful study around our findings and churn
  out money-making roadmaps. Our analysts have
  tracked high growth markets in chemicals
  materials, healthcare pharmaceuticals,
  semiconductor electronics, energy power, food
  retail, consumer goods, technology, and
  machinery equipment sectors across the world to
  identify new opportunities, potential customers,
  prepare go-to-market (GTM) strategies, identify
  segments for revenue growth for companies, and
  many more.

• US Headquarters3131 McKinney Ave Ste 600
  Dallas, TX 75204 ,U.S.A 

• Phone [phone]
• Email sales_at_adroitmarketresearch.com